Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine. The Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén
O
O
Department of Clinical Immunology, Huddinge Hospital, Stockholm, Sweden.
Labopin
M
M
Gluckman
E
E
Reiffers
J
J
Vernant
J P
JP
Jouet
J P
JP
Harousseau
J L
JL
Fiere
D
D
Bacigalupo
A
A
Frassoni
F
F
Gorin
N C
NC
D000208:Acute Disease; D016026:Bone Marrow Transplantation; D002908:Chronic Disease; D016001:Confidence Intervals; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006086:Graft vs Host Disease / Q000503:physiopathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D015999:Multivariate Analysis; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D011336:Probability; D012008:Recurrence; D012189:Retrospective Studies; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D008727:Methotrexate